Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1975 1
1976 1
1979 1
1980 2
1981 2
1982 1
1983 2
1984 1
1985 3
1986 3
1987 7
1988 3
1989 10
1990 9
1991 5
1992 5
1993 10
1994 6
1995 13
1996 10
1997 4
1998 11
1999 9
2000 9
2001 12
2002 4
2003 5
2004 10
2005 10
2006 19
2007 12
2008 12
2009 11
2010 13
2011 9
2012 8
2013 8
2014 11
2015 5
2016 7
2017 4
2018 7
2019 3
2020 6
2021 3
2022 3
2023 4
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

296 results

Results by year

Filters applied: . Clear all
Page 1
Multiple myeloma.
Anderson KC, Shaughnessy JD Jr, Barlogie B, Harousseau JL, Roodman GD. Anderson KC, et al. Among authors: roodman gd. Hematology Am Soc Hematol Educ Program. 2002:214-40. doi: 10.1182/asheducation-2002.1.214. Hematology Am Soc Hematol Educ Program. 2002. PMID: 12446425 Review.
Denosumab versus zoledronic acid in bone disease treatment of newly diagnosed multiple myeloma: an international, double-blind, double-dummy, randomised, controlled, phase 3 study.
Raje N, Terpos E, Willenbacher W, Shimizu K, García-Sanz R, Durie B, Legieć W, Krejčí M, Laribi K, Zhu L, Cheng P, Warner D, Roodman GD. Raje N, et al. Among authors: roodman gd. Lancet Oncol. 2018 Mar;19(3):370-381. doi: 10.1016/S1470-2045(18)30072-X. Epub 2018 Feb 9. Lancet Oncol. 2018. PMID: 29429912 Clinical Trial.
Osteoclast differentiation.
Roodman GD. Roodman GD. Crit Rev Oral Biol Med. 1991;2(3):389-409. doi: 10.1177/10454411910020030601. Crit Rev Oral Biol Med. 1991. PMID: 1892993 Review.
Therapeutic targets in myeloma bone disease.
Marino S, Petrusca DN, Roodman GD. Marino S, et al. Among authors: roodman gd. Br J Pharmacol. 2021 May;178(9):1907-1922. doi: 10.1111/bph.14889. Epub 2020 Feb 3. Br J Pharmacol. 2021. PMID: 31647573 Free article. Review.
Myeloma bone disease.
Callander NS, Roodman GD. Callander NS, et al. Among authors: roodman gd. Semin Hematol. 2001 Jul;38(3):276-85. doi: 10.1016/s0037-1963(01)90020-4. Semin Hematol. 2001. PMID: 11486316 Review.
Multiple Myeloma and Bone: The Fatal Interaction.
Marino S, Roodman GD. Marino S, et al. Among authors: roodman gd. Cold Spring Harb Perspect Med. 2018 Aug 1;8(8):a031286. doi: 10.1101/cshperspect.a031286. Cold Spring Harb Perspect Med. 2018. PMID: 29229668 Free PMC article. Review.
Osteocytes and Paget's Disease of Bone.
Tenshin H, Delgado-Calle J, Windle JJ, Roodman GD, Chirgwin JM, Kurihara N. Tenshin H, et al. Among authors: roodman gd. Curr Osteoporos Rep. 2024 Mar 8. doi: 10.1007/s11914-024-00863-5. Online ahead of print. Curr Osteoporos Rep. 2024. PMID: 38457001 Review.
Osteoblast suppression in multiple myeloma bone disease.
Adamik J, Galson DL, Roodman GD. Adamik J, et al. Among authors: roodman gd. J Bone Oncol. 2018 Sep 15;13:62-70. doi: 10.1016/j.jbo.2018.09.001. eCollection 2018 Nov. J Bone Oncol. 2018. PMID: 30591859 Free PMC article. Review.
Doubling Down on Wnt Signaling to Overcome Myeloma Bone Disease.
Delgado-Calle J, Roodman GD. Delgado-Calle J, et al. Among authors: roodman gd. J Bone Miner Res. 2023 Jun;38(6):812-813. doi: 10.1002/jbmr.4863. Epub 2023 Jun 5. J Bone Miner Res. 2023. PMID: 37277117 Free article. No abstract available.
296 results